2019-2020 Vision Network Publication Award Laureates
August 1st
Michel DESJARLAIS (prize supported by Fondation Antoine-Turmel)
Postdoctoral fellow, Université de Montréal
Laboratory : Dr Sylvain Chemtob
Publication: Desjarlais, M., Rivera JC, Lahaie I, Gagnone G, Wirt M, Omri S, Chemtob S. MicroRNA expression profile in oxygen-induced retinopathy model. PlosOne 2019 Jun 12;14(6)
Holder of a doctorate in biomedical science from the University of Montreal, I am currently a postdoctoral researcher in the laboratory of Dr. Sylvain Chemtob (MD, PhD) at the Maisonneuve Rosemont Hospital Research Center. My research aims to elucidate various mechanisms involved in the abnormal modulation of post-ischemic vascular repair (insufficient and excessive) during ischemic retinopathies (IRs). More specifically, I focus mainly on the identification of new post-transcriptional mechanisms including microRNAs that are altered during vascular degeneration. My postdoctoral research is a continuation of my doctoral thesis on the mechanisms modulating neovascularization during cardiovascular diseases. Passionate about science, my current research allows me to explore the function of microRNAs in vascular biology in a new pathological field (ophthalmology). I also hold a Master’s and a Bachelor’s degree in Biochemistry, and I am the recipient of over 15 Excellence Awards (including: 2015 and 2016 CRCHUM Publication Awards, Gold Awards at the CIHR Canadian Doctoral Student Competition health research in 2016), authors of 14 scientific articles including 7 as first authors and recipient of the CRHMR postdoctoral fellowship (2018) and the ophthalmology fund of the University of Montreal (2019).
***
Pascale DESJARDINS
PhD student, Université Laval
Laboratory : Dr Sylvain Guérin
Publication: Desjardins P, Couture C, Germain L, Guérin SL. Contribution of the WNK1 kinase to corneal wound healing using the tissue‐engineered human cornea as an in vitro model. J Tisue Eng Regen Med. 2019; 1–14.
I started my academic training in Biomedical Sciences at Université Laval. During my Bachelor’s degree, I had the chance to carry out many research internships in various fields of study. My first experience took place at the Centre Universitaire d’Ophtalmologie (CUO-Recherche / LOEX) at the CHU de Québec under the supervision of Dr. Sylvain Guérin. Afterwards, I also had the opportunity to work on Alzheimer’s disease, Eph receptor signalling in cancer and the development of the respiratory control system. These internships quickly confirmed my interest in research. Having particularly enjoyed studying at the Centre Universitaire d’Ophtalmologie, I renewed my experience with Dr. Sylvain Guerin when it was time to start my Master’s degree in Cellular and Molecular Biology in 2016. During my master’s degree, I studied the role of various signalling mediators, including CREB, Akt and more particularly WNK1, on corneal wound healing by using a human tissue-engineered cornea as model. As for my PhD, which I started last fall, I’m studying the specific contribution of the WNK1-SPAK/OSR1 signalling pathway and their effector proteins on corneal wound healing. In the last few years, I had the chance to travel to Honolulu, Greece and Switzerland to present the results of my works at international conferences. In addition, my works led to the publication of several scientific articles, in addition to leading to the establishment of a patent.
***
Seung Hyun (Sam) MIN
PhD student, McGill University
Laboratory : Dr Robert Hess
Publication: Min SH, Baldwin AS, Hess RF. Ocular dominance plasticity: A binocular combination task finds no cumulative effect with repeated patching. Vision Res. 2019 Aug;161:36-42
During high school, I was diagnosed with a nerve injury on my right hand from playing the clarinet, leaving me with no choice but to become ambidextrous. I had to longitudinally retrain my brain so that my left hand could properly write alphabets and hold chopsticks, the responsibilities that had been formerly assigned to my right hand. The experiences from my recovery sparked my interest in neural plasticity. For my undergraduate education, I pursued Anatomy and Cell Biology at McGill University and graduated within the top 10% of my class on June 2017. Since then, I have been working on my graduate degree at McGill University with Prof. Robert Hess on neural plasticity. The focus of my thesis has been on finding means to harness remaining levels of neural plasticity in the adult brain, a topic that parallels my experiences from playing music. I currently have three first author publications, two of which are from my graduate work. During spare time, I enjoy practicing the clarinet (yes, I still do play) and reading historical fiction novels. I am very grateful for the publication award and for all the support I have received from my mentors during my research training.
February 1st
Michel DESJARLAIS (prize supported by Fondation Antoine-Turmel)
Postdoctoral fellow, Université de Montréal
Laboratory : Dr Sylvain Chemtob
Publication: Desjarlais, M, Wirt M, Rivera JC, Lahaie I, Dabouz R, Omri S, Ruknudin P, Borras C, Chemtob S. microRNA-96 promotes vascular repair in oxygen-induced retinopathy – a novel uncovered vasoprotective function. Front. Pharmacol. 2020 Feb 3; https://doi.org/10.3389/fphar.2020.00013
With a doctorate in biomedical science from the University of Montreal, I am currently a postdoctoral researcher in the laboratory of Dr. Sylvain Chemtob (MD, PhD) at the research center of Maisonneuve Rosemont Hospital. My research aims to elucidate different mechanisms involved in pathological modulation vascular development and vascular repair (insufficient and excessive) during ischemic retinopathies (IRs). More specifically, I mainly focus on the identification of new post-transcriptional mechanisms including micro-RNAs which are altered during vascular degeneration. My postdoctoral research represents a continuation of my previous research carried out during my doctorate on the modulation of the mechanisms of neovascularization in cardiovascular diseases. Passionate about science, my research allows me to explore the function of micro-RNAs in vascular biology in a new pathological field (ophthalmology). I also hold a master’s and bachelor’s degree in biochemistry, and I am the recipient of more than 15 excellence awards (including publication awards: 2015 and 2016 CRCHUM, 2019 RRVS), also recipient of the gold awards in 2017 at Canadian Congress of Doctoral Students in Health Research and, authors of 16 scientific articles, including 8 as first authors. I am also a recipient of the CRHMR postdoctoral fellowship (2018) and the ophthalmology funding of the University of Montreal (2019, 2020).
***
Tianwei Ellen ZHOU (prize supported by Fondation Antoine-Turmel)
Resident, Université de Montréal
Laboratory : Dr Sylvain Chemtob
Publication: Zhou TE, Zhu T, Rivera JC, Omri S, Tahiri H, Lahaie I, Rouget R, Wirth M, Nattel S, Lodygensky G, Ferbeyre G, Nezhady M, Desjarlais M, Chemtob S. The Inability of the Choroid to Revascularize in Oxygen-Induced Retinopathy Results from Increased P53/mir-Let-7b Activity. Am J Pathol. 2019 Nov; 189 (11):2340-2356
Driven by curiosity, I joint the Montreal Chest Institute for Cystic Fibrosis research as an undergraduate student. I met Dr. James Martin, a respirologist, who inspired me to join McGill’s MD-PhD program, a path that brings together medical innovation and compassionate care. During my PhD, I worked with Dr. Sylvain Chemtob, a neonatologist, and dedicated my thesis to Retinopathy of Prematurity, a blinding eye disease that threatens the sight of premature babies. My studies show that ROP is not a static disease, but a dynamic progression that can precipitate long-term retinal damages, highlighting the importance of longitudinal follow-ups for ROP patients. With gratitude, my research endeavour was supported by numerous national and provincial scholarships, including the Fonds Suzanne Véronneau- Troutman, the CIHR MD/PhD Program Grant and FRQS PhD award. Upon graduating from medical school in 2019, I was honoured with the Scriver-Steinberg Convocation Prize which “recognizes a graduate with exceptional potential to translate knowledge into practice to make a difference in the well-being of patient, family, or community”. As an ophthalmology resident at the University of Montreal, I am translating the PhD thesis into a clinical study, which examines 1) if infants with ROP sustain retinal injuries throughout their childhood and adolescence; and 2) if ROP patients have a higher risk of developing retinal diseases (especially AMD) in their adulthood. I hope this project would help us better characterize the long-term implications of ROP, and detect early signs of age-related retinal injuries among ex- ROP patients.